Chevron deal to buy Hess at risk as Exxon, CNOOC eye Guyana stake
By Steve Goldstein
Chevron warned it may not complete its planned buyout of Hess as Exxon Mobil and the China National Offshore Oil Corporation are saying the planned deal would trigger their right to boost their stakes in a Guyana venture.
The warning came in a Securities and Exchange Commission filing, which says that both Exxon and CNOOC informed Hess (HES) and Chevron (CVX) that the U.S. deal triggers a change-of-control provision allowing them to boost their stakes.
Right now, the companies are in talks to resolve the issue, and if necessary they can go to arbitration. If all of that doesn't work, Chevron said it would not complete the Hess deal.
"Chevron and Hess do not believe there is any material likelihood that the circumstances described in this paragraph will occur," said the filing.
Hess has a 30% ownership of the Guyana venture, which has more than 11 billion barrels of oil equivalent. Exxon (XOM) has control of 45% of the venture, and CNOOC (HK:883) has a 25% stake.
The Chevron all-stock offer, initially valued at $53 billion, is now valued at $157.85 per share, or 7% less than the value at announcement.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
02-27-24 0449ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Cognizant Earnings: Improved Profitability Buttresses Results as Customer Spending Remains Muted
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts